Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma.

Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma.
复制标题

DOI:
10.1038/leu.2008.291
复制
发表时间:
2009-01
期刊:
影响因子:
11.4
通讯作者:
Rajkumar, S. V.
Rajkumar, S. V.
中科院分区:
医学1区
文献类型:
--
作者:
Kyle, R. A.;Rajkumar, S. V.

文献摘要

参考文献

被引文献

相似文献

已经出现了用于多发性骨髓瘤(MM)的诊断、分期和反应评估的新系统。推荐的诊断和反应标准主要来自国际骨髓瘤工作组,并进行了某些更新和澄清。国际分期系统是目前骨髓瘤分期的标准。提供了一种新的风险分层模型,以明确定义可能受益于新型治疗策略的高风险患者。本文提供了MM的诊断、分期、危险分层和疗效评估的现行标准。
New systems have emerged for diagnosis, staging and response assessment in multiple myeloma (MM). The diagnostic and response criteria recommended are primarily derived from the International Myeloma Working Group, with certain updates and clarifications. The International Staging System is the current standard for staging of myeloma. A new risk stratification model is provided to specifically define high-risk patients who may benefit from novel therapeutic strategies. This paper provides the current criteria for diagnosis, staging, risk stratification and response assessment of MM.
DOI: 10.1182/blood.v86.11.4250.bloodjournal86114250
发表时间: 1995-12-01
期刊: BLOOD
影响因子: 20.3
作者:
TRICOT, G;BARLOGIE, B;SAWYER, JR
通讯作者: SAWYER, JR
DOI: 10.1016/s0889-8588(05)70124-6
发表时间: 1999-12-01
影响因子: 2.4
作者:
Dimopoulos, MA;Kiamouris, C;Moulopoulos, LA
通讯作者: Moulopoulos, LA
DOI: 10.1182/blood.v98.7.2229
发表时间: 2001-10-01
期刊: BLOOD
影响因子: 20.3
作者:
Smadja, NV;Bastard, C;Fruchart, C
通讯作者: Fruchart, C
DOI: 10.1182/blood-2006-04-015784
发表时间: 2006-09-15
期刊: BLOOD
影响因子: 20.3
作者:
Dingli, David;Kyle, Robert A.;Katzmann, Jerry A.
通讯作者: Katzmann, Jerry A.
DOI: 10.1038/sj.leu.2404284
发表时间: 2006-09-01
期刊: LEUKEMIA
影响因子: 11.4
作者:
Durie, B. G. M.;Harousseau, J-L;Rajkumar, S. V.
通讯作者: Rajkumar, S. V.